{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9(3)"],"submitter":["Okuma Y"],"journal":["Journal of thoracic disease"],"pagination":["470-473"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5394089"],"repository":["biostudies-literature"],"pubmed_title":["Osimertinib for advanced non-small cell lung cancer harboring EGFR mutation exon 20 T790M, acquired resistant mutation for first- or second-generation EGFR-TKI."],"pmcid":["PMC5394089"],"pubmed_authors":["Okuma Y","Hosomi Y"],"additional_accession":[]},"is_claimable":false,"name":"Osimertinib for advanced non-small cell lung cancer harboring EGFR mutation exon 20 T790M, acquired resistant mutation for first- or second-generation EGFR-TKI.","description":null,"dates":{"release":"2017-01-01T00:00:00Z","publication":"2017 Mar","modification":"2025-04-19T17:16:22.111Z","creation":"2025-04-19T17:16:22.111Z"},"accession":"S-EPMC5394089","cross_references":{"pubmed":["28449447"],"doi":["10.21037/jtd.2017.03.26"]}}